Viewing StudyNCT05306041



Ignite Creation Date: 2024-05-06 @ 5:25 PM
Last Modification Date: 2024-10-26 @ 2:28 PM
Study NCT ID: NCT05306041
Status: RECRUITING
Last Update Posted: 2024-02-22
First Post: 2022-03-09

Brief Title: Neoadjuvant Endocrine Therapy - the PI3K Inhibitor Inavolisib in HER2 HR PIK3CA Mutant Early Breast Cancer
Sponsor:
Organization: German Breast Group